Series C · Healthtech

CereVasc raises $85M Series C

CereVasc raised $85 million in Series C financing announced in June.

Piper Sandler Merchant Banking, Johnson & Johnson Innovation–JJDC, Medtronic, Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds are among its backers.

The company develops the minimally invasive eShunt System for communicating hydrocephalus and other neurological diseases.

Funding history

Series C · This round$85M

Sources

  1. CereVascprojectstartups.com
  2. businesswire.com